Three Types — and Why the Distinction Matters
Sleep apnea is the repeated cessation of breathing during sleep. There are three types, and the treatment for each is different. Getting the wrong treatment — which happens routinely when the diagnosis is driven by insurance constraints rather than clinical accuracy — does not just fail to help. It can accelerate decline.
Obstructive (OSA)
The airway physically collapses. The brain signals breathing, the muscles don't keep the airway open. Structural — jaw, tongue, throat anatomy, body position, muscle tone. Most common type. CPAP addresses this mechanically by pressurizing the airway.
Central (CSA)
The brain fails to send the signal to breathe. The airway is open — the signal never comes. Associated with heart failure, brainstem dysfunction, opioid use, altitude, and in some presentations, neurological stress from chronic EMF exposure. CPAP does not treat this and can worsen it.
Mixed / Complex
Both central and obstructive components present. Requires BiPAP or ASV (adaptive servo-ventilation) for adequate treatment. Insurance frequently denies BiPAP authorization even when clinical testing indicates it is necessary — forcing patients onto CPAP that only addresses half their problem.
Medications That Alter the Brain's Breathing Signal
Central and mixed sleep apnea are not only structural or environmental — they are frequently medication-induced or medication-worsened. Any drug that affects the central nervous system can alter the brain's respiratory drive signal. This is almost never reviewed as part of a sleep apnea workup.
Heart failure & cardiovascular medications
- Digoxin — directly associated with central apnea in heart failure
- Certain beta-blockers — alter respiratory drive and autonomic regulation
- Diuretics — electrolyte shifts affect neuromuscular signaling
Pain & sedative medications
- Opioids — directly suppress medullary respiratory neurons
- Benzodiazepines — respiratory depression, reduced hypercapnic response
- Muscle relaxants (baclofen, cyclobenzaprine) — reduce upper airway tone
- Gabapentin & pregabalin — respiratory depression, particularly in combination
- Zolpidem & other sleep medications — suppress arousal response to apnea events
Psychiatric & neurological medications
- Tricyclic antidepressants (amitriptyline, nortriptyline, doxepin) — sedating, can worsen obstructive events
- Mirtazapine, trazodone — sedating antihistamine mechanism, weight gain
- Some SSRIs & SNRIs — variable; can affect autonomic respiratory regulation
- Antipsychotics — sedation, weight gain, reduced arousal response
The combination problem
Any combination of two or more CNS-affecting medications — even at individually "safe" doses — can produce additive respiratory depression. A patient on an antidepressant, a sleep medication, and a pain medication is not on three medications. They are on one combined respiratory risk.
The Insurance Gatekeeping Problem
Most insurance-covered sleep testing is a home sleep apnea test (HSAT) — a portable device the patient wears at home for one night. HSATs measure airflow, chest movement, and oxygen saturation. They do not reliably detect central apnea. They do not detect the neurological signal failure — they only measure whether the airway is open or not. A patient with significant central apnea can pass an HSAT with a deceptively low AHI (apnea-hypopnea index).
Full polysomnography (in-lab sleep study) measures EEG, EMG, ECG, respiratory effort, airflow, and oxygen simultaneously — the only test that reliably distinguishes obstructive from central events. Insurance typically requires HSAT first and authorizes polysomnography only if the HSAT is inconclusive or failed.
The result: a patient with mixed or complex apnea gets diagnosed based on an inadequate test, prescribed CPAP for obstructive apnea, and the central component is never identified. They don't improve. Their provider assumes non-compliance or inadequate pressure. The patient declines. No one looks at the diagnosis.
A documented case:
A patient underwent full in-lab polysomnography in 2018 — the gold standard test. The study confirmed both obstructive and central apnea components. Both were documented. The treating provider and insurance carrier still authorized CPAP only — the device designed for obstructive apnea. The central component was never treated. The patient continued to decline. Symptoms included excessive sweating throughout the day and night (autonomic dysregulation), uncontrolled blood sugar on medication, and uncontrolled blood pressure on medication. Medication contributions to central apnea were not reviewed. Environmental contributors — including bedroom Wi-Fi and in-floor heat — were never considered. The CPAP data looked compliant. The patient kept declining. The system saw compliance, not a person.
Retractive Orthodontia and the Airway Crisis in Young People
Sleep apnea is increasingly being diagnosed in children, adolescents, and young adults — populations where, a generation ago, it was rare enough to be considered exceptional. The question most orthodontists and pediatric sleep specialists are not asking: what changed in how we develop jaws?
The answer involves two converging factors: the modern diet and the orthodontic philosophy that dominated the second half of the 20th century.
The Jaw Development Problem
Human jaw development requires mechanical loading — chewing hard, fibrous, raw, and chewy foods from early childhood onward. The mechanical stress of chewing stimulates bone remodeling in the maxilla and mandible, widening the palate and creating space for the full complement of adult teeth. Modern processed and soft food diets — beginning in infancy with pureed foods and continuing through childhood — remove this developmental stimulus. The result, documented by researchers including Dr. Sandra Kahn and Dr. Paul Ehrlich in Jaws: The Story of a Hidden Epidemic (2018), is that modern human jaws are systematically underdeveloped compared to pre-industrial skulls. Narrower palates. Less room for teeth. Smaller airways.
What Retractive Orthodontia Does to the Airway
The dominant orthodontic philosophy of the 20th century addressed overcrowded teeth by extracting premolars — typically four teeth, one in each quadrant — and then using braces to retract (pull back) the remaining teeth to close the space. The result looks correct from the front: straight teeth, closed extraction gaps. The structural result is a jaw that has been moved posteriorly — further back in the skull — along with the tongue that sits on the floor of that jaw.
The tongue moves with the jaw. When the jaw is retracted, the tongue is retracted. The posterior airway space — the three-dimensional opening behind the tongue — narrows. In a patient who already has a small jaw from inadequate developmental loading, extraction and retraction orthodontics can be the final step that takes a marginal airway to a clinically obstructed one.
Orthotropic and airway-focused orthodontists — including Dr. John Mew and Dr. Mike Mew, who have advocated for forward-development orthodontics for decades — have documented this mechanism. Their clinical position: the goal of orthodontics should be to develop the jaw forward and outward to its genetic potential, not to extract teeth and retract the existing structure. The conventional orthodontic establishment has largely resisted this framework, but the connection between retractive treatment and sleep-disordered breathing is increasingly appearing in the peer-reviewed literature.
What this means for children presenting with apnea or snoring
Before any child is prescribed a CPAP or referred for adenotonsillectomy, the jaw development question deserves evaluation. Is the palate narrow? Has retraction orthodontia already occurred? Is there a tongue tie (ankyloglossia) restricting tongue posture and jaw development? Functional orthodontic approaches — palate expansion, myofunctional therapy, tongue tie release — may address the structural root cause rather than managing symptoms with equipment. Find an airway-focused orthodontist or a biological dentist trained in craniofacial development.
Tonsillectomy & Adenoid Removal — What the Surgery Doesn't Address
The upstream question: did this start at birth?
Cranial nerve compression during delivery — particularly of the vagus (CN X) and hypoglossal (CN XII) nerves — directly affects tongue posture, pharyngeal tone, and airway architecture from day one. A baby who couldn't latch properly, had a head tilt preference, or showed colic and reflux may have had impinged cranial nerve function that drove the mouth breathing and adenoid hypertrophy now being addressed surgically. The tongue is the scaffold of the airway. If it never sat correctly on the palate, the jaw never developed the space the airway needed. See Birth Trauma: The Unexamined Origin for the full cranial nerve chain.
Tonsils and adenoids are lymphoid tissue — the first immunological checkpoint in the nasopharynx. They are not design errors. They are part of the immune surveillance system, and their enlargement is almost always a signal that the body is under active immunological burden: chronic infection, food reactivity (dairy is the most common driver), environmental allergen exposure, or biotoxin burden from mold or other environmental sources.
When enlarged tonsils or adenoids physically obstruct the airway — particularly in children — they do contribute directly to sleep-disordered breathing, snoring, and obstructive apnea events. Removing them resolves the obstruction. That part is accurate. What the surgical conversation rarely includes is the question of why the tissue is enlarged in the first place.
What the surgery does
- Removes the physical obstruction — immediate improvement in airflow
- Often resolves pediatric obstructive sleep apnea in the short term
- Reduces snoring, mouth breathing, and nighttime waking in most cases
What the surgery doesn't address
- The reason the tissue was chronically inflamed and enlarged
- The food reactivity (dairy, gluten) driving recurrent inflammation
- The environmental allergen or biotoxin burden
- The jaw development picture — a narrow palate will still be narrow post-surgery
- The loss of immune tissue at the first-line lymphatic checkpoint
Children who have adenotonsillectomy without addressing the underlying inflammatory driver frequently continue to have airway and immune challenges — recurrent respiratory infections, allergies, and in some cases a return of sleep-disordered breathing as the remaining airway anatomy is still developmentally compromised. The surgery treats the symptom. The cause remains active.
Before scheduling the surgery, ask:
- Has dairy been removed from the diet for a minimum of 6–8 weeks to assess the inflammatory response?
- Has the home been assessed for mold or water damage — tonsil hypertrophy is a documented response to mycotoxin burden
- Has the child been evaluated for tongue tie, which affects tongue posture and contributes to mouth breathing and adenoid hypertrophy?
- Is this a narrow palate situation where expansion would create more space without tissue removal?
Long-term consequences that don't get discussed before the surgery
- ARFID (Avoidant/Restrictive Food Intake Disorder) — Post-surgical throat sensitivity, scarring, and altered swallowing mechanics can create fear of choking and food texture aversion that becomes entrenched. In children especially, the surgical experience + recovery pain + swallowing difficulty during healing can rewire the relationship with eating in ways that persist for years. ARFID following adenotonsillectomy is underreported and rarely connected to the surgery when it appears months later.
- Heart and cardiovascular consequences — Tonsil and adenoid tissue is primary lymphoid tissue — part of Waldeyer's ring, the first immunological checkpoint of the nasopharynx. Removal permanently alters immune surveillance of the upper respiratory tract. Long-term studies have shown associations between adenotonsillectomy and increased risk of respiratory infections, allergic disease, and in some analyses, autoimmune and cardiometabolic conditions. The tissue was there for a reason.
- Sleep apnea returns — When the structural and inflammatory drivers are not addressed, the airway problem does not resolve with surgery — it resumes. A narrow palate is still narrow. A tongue tie still affects tongue posture. Dairy-driven inflammation still inflames. Children who have adenotonsillectomy without correcting the root causes frequently develop obstructive sleep apnea again as adults, often worse than before because the jaw and airway anatomy was never developed correctly.
When the Building Is Part of the Diagnosis
Sleep apnea that doesn't respond to treatment — or that keeps worsening despite compliance — is often read as a patient problem. The machine isn't working because the patient isn't using it correctly, isn't losing weight, isn't sleeping in the right position. What is rarely asked: what is the patient sleeping in?
Chronic biotoxin illness from water-damaged buildings (CIRS) produces neuroinflammation — measurable, documented, and particularly concentrated in structures involved in brainstem and autonomic function. The brainstem is where the respiratory drive originates. When brainstem signaling is impaired by ongoing biotoxin burden, the brain's ability to maintain consistent respiratory drive during sleep is compromised. This is not theoretical. It is the mechanism of central sleep apnea — and mold illness is an upstream cause that the sleep medicine workup almost never evaluates.
Mold → Central Apnea
Biotoxin-driven neuroinflammation impairs brainstem respiratory control. The brain fails to signal breathing — not because the airway is blocked, but because the signal is disrupted at the source. CPAP cannot fix this. In some cases it worsens it.
Mold → Obstructive Apnea
Mold exposure drives chronic nasal and sinus inflammation, swelling the tissue that lines the upper airway. Nasal obstruction promotes mouth breathing, drops the tongue, and narrows the posterior airway space — directly contributing to obstructive events during sleep.
The Closed Loop
Mold illness impairs sleep. Impaired sleep impairs drainage — the lymphatic system, the glymphatic brain-clearance system, the liver's detoxification window. When drainage is impaired, biotoxin burden accumulates faster than the body can clear it. Accumulated biotoxins drive more neuroinflammation. More neuroinflammation disrupts sleep further. The loop is self-reinforcing, and it runs in both directions: the mold worsens the apnea and the apnea worsens the mold burden. Neither resolves while the other is active and unaddressed.
Add EMF into this environment — the CPAP machine's cellular modem transmitting at the head all night, in a building that already has high ambient RF from fiber installation, smart meter, and wireless devices — and the biological stress compounds. EMF accelerates fungal metabolism. The building becomes more toxic. The patient becomes more symptomatic. The CPAP compliance data looks fine. No one is looking at the building.
The question to ask first
Has this person ever been in a water-damaged building — home, school, workplace, or vehicle? Does the apnea have central components that don't respond to CPAP? Do symptoms improve when they travel and sleep somewhere else? If yes to any of these, the building needs to be evaluated before any further sleep intervention is optimized. You cannot address the apnea while the upstream cause is active.
This is also where the structural picture matters. Nasal asymmetry, cranial compression patterns from birth trauma, jaw development — these are not separate from mold illness. Chronically inflamed and structurally compromised nasal passages both restrict the airway and create a hospitable environment for fungal colonization. The structural and the environmental cannot be addressed in isolation. See The Foundation of Assessment for how these systems connect before any diagnosis or protocol begins.
How You Breathe Shapes How You Develop — and How You Sleep
Nasal breathing is not just a preference. It is a developmental requirement. The tongue resting on the roof of the mouth — proper tongue posture, or "mewing" in the popular lexicon — is the mechanical force that develops the maxilla forward and wide. Nasal breathing is what positions the tongue correctly. Mouth breathing drops the tongue to the floor of the mouth, removes the developmental pressure from the palate, and allows the midface to develop narrow and recessed.
A mouth-breathing child is developing a narrower jaw, a higher and narrower palate, and a smaller posterior airway — simultaneously. The chronic upper respiratory infections, allergies, and enlarged adenoids that promote mouth breathing in childhood are not incidental. They are structural contributors to the airway crisis that shows up as sleep apnea in adulthood.
The Buteyko method, the Patrick McKeown (Oxygen Advantage) approach, and the Petkus Optimal Circadian Health protocol all converge on the same practical starting point: restore nasal breathing, restore CO₂ tolerance, and allow the body's natural airway-opening physiology to function. These are not complementary add-ons to machine therapy. For a meaningful subset of patients, they are a path out of machine dependency entirely.
A Machine with a Cellular Modem — Positioned at Your Head, All Night
The ResMed AirSense 10 and AirSense 11 — the two most commonly prescribed CPAP machines in the United States — contain built-in LTE cellular modems. The modem transmits sleep data nightly to cloud servers for remote monitoring by the prescribing physician and the insurance company. This transmission occurs while the machine is running. While the patient is sleeping. With the machine six to eighteen inches from the patient's head.
Many models also include Bluetooth for pairing with smartphone apps. Some include Wi-Fi. The patient is prescribed a device to improve their sleep and brain oxygenation that continuously irradiates their head with pulsed RF throughout the night — the period of sleep when the brain performs glymphatic clearance, cellular repair, and memory consolidation. The period when EMF exposure is most biologically costly.
Central sleep apnea has documented associations with neurological stress, brainstem dysregulation, and cardiac autonomic dysfunction. If non-native EMF disrupts autonomic regulation and brainstem signaling — as the voltage-gated calcium channel research suggests it does — then placing a cellular-transmitting device at the head of a patient with central apnea is not a neutral intervention. It is adding an environmental neurological stressor to a patient who already has impaired neurological breathing control.
The mold connection
Central sleep apnea has a neurological origin — the brainstem fails to signal breathing. Chronic biotoxin exposure from water-damaged buildings (CIRS) produces measurable neuroinflammation in brainstem structures involved in respiratory control. Mold illness is an underrecognized upstream cause of central and mixed apnea — and it is almost never evaluated in a standard sleep workup. If you have sleep apnea that does not respond to CPAP, or that has central components, and you live or work in a building with any history of water damage: the building deserves investigation before any further machine adjustments. See Sick Buildings: Mold, EMF, Fiber Optic & Radiant Heat for the full picture.
What to do if you currently use a CPAP or BiPAP
- • Disable the cellular modem: most ResMed and Philips machines allow the cellular modem to be disabled in settings. Contact your DME supplier or the manufacturer — they may resist (monitoring is required by insurance for compliance verification) but it is technically possible on most devices.
- • Disable Bluetooth when not actively syncing data. Bluetooth can be turned off between sessions.
- • Move the machine as far from your head as the tubing allows. Six extra feet of standard 6-foot tubing costs under $20 and doubles your distance from the device.
- • Use an older, non-connected CPAP model if possible — pre-2015 machines had no cellular modem. Used machines are widely available; compliance data is not transmitted, but the therapy functions identically.
- • Work toward addressing the structural cause — if nasal breathing, myofunctional therapy, and positional changes can reduce your AHI sufficiently, the machine becomes optional.